Forbes Earnings Preview: PDL BioPharma

Analysts have become increasingly bullish on PDL BioPharma (PDLI) in the month leading up to the company's first quarter earnings announcement scheduled for Thursday, May 9, 2013. The consensus earnings per share estimate has moved up from 34 cents a share to the current expectation of earnings of 36 cents a share.